Blog

  • Now playing: Broad Paper Vids

    Veronica Meade-Kelly, May 23rd, 2014

    In the coming months, a new video series on the Broad’s popular YouTube channel will introduce viewers to published research – from the scientist’s perspective. In each installment of the “Broad Paper Vids” series, institute researchers will describe the exciting scientific discoveries that have made their way from the Broad to the pages of respected scientific journals.

    0 Comments
    Read More
  • Broad core member awarded National Science Foundation’s highest honor

    Leah Eisenstadt, April 10th, 2014

    Broad Institute core faculty member Feng Zhang has been named the 2014 recipient of the Alan T. Waterman Award from the National Science Foundation. The award, named after the NSF’s first director, is the agency’s highest honor, which annually recognizes an outstanding researcher under the age of 35. Zhang’s award will help support his work to understand how the brain works.

    0 Comments
    Read More
  • Glioblastoma’s “stem-like” cells laid bare

    Haley Bridger, April 10th, 2014

    What: Glioblastoma, the most common and most aggressive form of brain cancer in adults, remains effectively incurable. Evidence suggests that “stem-like” cells help drive this difficult-to-treat disease. These cells may possess properties that give them the ability to resist treatment and drive cancer’s growth, but pinpointing them and understanding the circuitry that makes them behave the way they do has been a major challenge.

    0 Comments
    Read More
  • Studies converge on ALS

    Veronica Meade-Kelly, April 4th, 2014

    What: Researchers from the Broad Institute, the Harvard Stem Cell Institute (HSCI), and Boston Children’s Hospital (BCH) used an eclectic combination of cutting-edge technologies to determine what’s going wrong at the molecular level in the neurodegenerative disease amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. Their research, published online this week in two separate Cell journals, sheds light on the mechanisms that lead to the disease and highlights potential targets for new treatments.

    0 Comments
    Read More
  • Kerstin Lindblad-Toh receives major award from Swedish Research Council

    Paul Goldsmith, March 31st, 2014

    This week, Broad scientific director of vertebrate genome biology Kerstin Lindblad-Toh became one of the first recipients of a new long-term research grant from the Swedish Research Council. The program, known as Grants for Distinguished Professors, provides Swedish scientists with 10 years of flexible funding to support ambitious, long-term projects. Lindblad-Toh is one of only nine researchers selected to receive the inaugural award.

    0 Comments
    Read More
  • Insights into drug resistance for a rare leukemia

    Haley Bridger, March 3rd, 2014

    What: For patients with T cell acute lymphoblastic leukemia (T-ALL), a rare form of blood cancer that mainly affects children and young adults, drug resistance poses a major threat to a promising treatment option currently in clinical trials. About half of patients with T-ALL have mutations in NOTCH1, but drugs that target this gene have so far produced only short-lived effects: at first, the cancer seems to respond, but in a short period of time, T-ALL returns.

    0 Comments
    Read More
  • Setting the standard in proteomics

    Veronica Meade-Kelly, February 27th, 2014

    What: Members of the Broad’s Proteomics Platform were the lead authors of a recent paper that outlined best practices for developing and publishing studies involving one of the field’s signature tools: targeted mass spectrometry (MS).

    0 Comments
    Read More
  • Putting a neglected disease in the spotlight

    Paul Goldsmith, February 6th, 2014

    Heard of Chagas disease? Chances are, unless you live in Central or South America where the disease affects an estimated 8 million people, you probably haven’t.

    1 Comments
    Read More
  • Single driver mutation found in rare brain tumor

    Leah Eisenstadt, January 30th, 2014

    For patients with a rare brain tumor known as craniopharyngioma, the treatment options are slim — and often hazardous. Although the tumor is usually not aggressive, its location is perilous. Growing at the base of the skull near the pituitary gland, the tumor compresses parts of the brain as it enlarges, causing vision and learning problems and endocrine dysfunction, as well as morbid obesity. There is currently no drug to shrink the tumor, so the only options are surgical removal and radiation, which can leave patients with serious, lasting problems.

    0 Comments
    Read More
  • Ancestral legacy

    Veronica Meade-Kelly, January 29th, 2014

    It’s part of human nature: we look at ourselves in the mirror and see links to the past. “Those bright green eyes?” we think. “Those came from grandma.” “The cleft chin? That’s from dad’s side.” Our instinct, of course, is to attribute notable traits to close relatives – those that we know personally or through family history. The reality, however, is that the genetics that influence our traits – or “phenotypes” – could date back generations.

    0 Comments
    Read More